Renal Disease Research Institute

Discover the Renal Disease Research Institute’s innovative tool that allows you to search for clinical studies tailored to your specific diagnosis, kidney disease stage, and presence of proteinuria. Visit our page today to explore this powerful feature! We're dedicated to bridging the gap between patients, doctors, and vital research studies. This tool is just one of the many ways we're working to make this process more efficient and accessible. https://lnkd.in/dP26XMCD

The AMPLITUDE study is researching an investigational drug for APOL1-mediated kidney disease, a type of chronic kidney disease affecting people of African ancestry. Visit our website to learn more about this study and reach out to our team with any questions: https://lnkd.in/dP26XMCD #KidneyDisease #AMPLITUDEStudy

Join us on today on Good Morning Texas on WFAA Channel 8 at 9 am for an informative segment with nephrologist Dr. Roberto Collazo-Maldonado. He will share the latest treatment options for people dealing with kidney disease. Hope to see you there!

Mark your calendars for August 13 and watch Good Morning Texas on WFAA Channel 8 at 9 am for an informative segment about the new treatment options available for people with kidney disease. You won't want to miss it!

Wondering about side effects in clinical trials? These are any undesired effects from the study medication or treatment. Side effects can vary by study, and treatments are carefully assessed for both immediate and long-term impacts. All known potential side effects are disclosed before participation, so you can make an informed decision. #ClinicalTrials #MedicalResearch #Healthcare"

Clinical trials offer a unique opportunity for eligible volunteers to play an active role in their healthcare. Participants can access new treatments before they're widely available and contribute to advancing medical research. However, it's important to be aware of the potential risks, including time commitments, the possibility that the treatment may not work, and the chance of experiencing serious side effects. Always consult with healthcare professionals to understand both the benefits and risks involved. #ClinicalTrials #MedicalResearch #Healthcare

WHAT TRIALS ARE CURRENTLY AVAILABLE? Renal Disease Research Institute (RDRI) is currently conducting multiple clinical trials and looking for volunteers. If you are interested, talk to your doctor. For more information about Renal Disease Research Institute trials based on your kidney disease diagnosis, visit https://lnkd.in/dP26XMCD

WHAT HAPPENS WHEN YOU VOLUNTEER? Thinking about joining our study? Here's what to expect: 1. The RDRI research team will talk to you about the study. You will be asked to sign a consent and will be given a copy. The consent form explains why the study is being done and what the study involves (including the chance of receiving a placebo). A placebo is a pill that does not contain active medicine. The consent form also explains possible side effects and how data collected about you will be used. 2. If you agree to join the study, a screening visit occurs. At the screening visit, the research team collects your medical history, and lab tests are performed. The information collected will determine if you can join the study. 3. If you join the study, the RDRI research doctor will begin closely monitoring your health. You will attend study visits at the clinic for physical exams and lab tests. You will also be asked to report side effects or changes to your health. 4. You will continue to see your own doctor for your routine healthcare. At your request, test results will be shared with your doctor.

WHY VOLUNTEER FOR A CLINICAL TRIAL? Joining a study is a way to help others and possibly yourself by contributing to new scientific research. Research studies are very important for the development of new medications and devices to treat chronic kidney diseases.

WHAT IS A CLINICAL TRIAL? A clinical trial is also called a research study. During a research study, patients are asked if they would like to join a study to test a new treatment.